Targeting the PIM protein kinases for the treatment of a T-cell acute lymphoblastic leukemia subset - Wikidata - awgldk - TriplyDB

Targeting the PIM protein kinases for the treatment of a T-cell acute lymphoblastic leukemia subset

Targeting the PIM protein kinases for the treatment of a T-cell acute lymphoblastic leukemia subset

http://www.wikidata.org/entity/Q33728277

about

PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity.STAT5 is essential for IL-7-mediated viability, growth, and proliferation of T-cell acute lymphoblastic leukemia cells

P2860

Q54978680-8ACB8D5F-891F-49DA-B7F3-FF88DA8AB6D2 Q58762852-7B2240F0-EB74-4C70-A860-DFDC045DCA35

P2860

Targeting the PIM protein kinases for the treatment of a T-cell acute lymphoblastic leukemia subset

http://www.wikidata.org/entity/Q33728277

description

2017 nî lūn-bûn

@nan

2017 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մարտին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Targeting the PIM protein kina ...... lymphoblastic leukemia subset

@ast

Targeting the PIM protein kina ...... lymphoblastic leukemia subset

@en

type

label

Targeting the PIM protein kina ...... lymphoblastic leukemia subset

@ast

Targeting the PIM protein kina ...... lymphoblastic leukemia subset

@en

prefLabel

Targeting the PIM protein kina ...... lymphoblastic leukemia subset

@ast

Targeting the PIM protein kina ...... lymphoblastic leukemia subset

@en

P1433

Q33728277-0EBB364A-CE5D-424F-965B-813498E07F2F

P1476

Q33728277-B5E7EE36-8E81-476B-9B45-1BCC988DAFDE

P2093

Q33728277-017C2A90-DEF9-489F-BC1A-6F24D74BFBBC

Q33728277-0CC7C678-8A79-4FDD-8BE2-330392800C7F

Q33728277-616D8D68-2593-4C0D-A4C8-F10D2A89FD34

Q33728277-8B35949C-309F-4783-9EF2-39147729A48B

Q33728277-8FF47D35-6B0C-496E-AC25-B426CCA39985

Q33728277-B7460666-3845-47A1-9A1D-F1846148F0EE

Q33728277-CF8D1BB8-F02F-4693-A715-33CC8C302C97

Q33728277-D8CAAA15-82BC-479B-B509-81C74C479689

Q33728277-EDEDF9DD-21BC-4DB2-A181-0FE5C9D9F953

P2860

Q33728277-0312664A-D06A-4E52-AE3B-F81F1572EC45

Q33728277-0832ED06-6D76-4985-9CC3-9D83D80F0A51

Q33728277-0875D5AA-997C-4261-A927-4D282D575A5E

Q33728277-089698FA-C647-4C18-8958-CEBCBA99CBAF

Q33728277-11EDF139-5951-4EFB-8211-DA18F475EF25

Q33728277-15ECC78A-2DC8-4E52-B204-260B83EB7519

Q33728277-16FEE47C-C1F7-4A85-B66C-4E1FF2C1D8A9

Q33728277-173D5255-9B6E-4273-BA24-3B4568EF43E4

Q33728277-247A5248-D4B4-482C-83FB-982090FACA78

Q33728277-24E3F678-9DE4-431B-BFA9-7257300C07FC

P304

Q33728277-8B34F83C-078C-4F96-BBC4-D5D24CF517D6

P31

Q33728277-F1681BA1-6910-41DD-865E-85B83A7D77BE

P356

Q33728277-DD926A6F-BB19-406A-AE0D-17B3BB6FD131

P407

Q33728277-B39008FE-4C40-40FC-8D71-796A01DE924C

P433

Q33728277-84A13820-FE03-4654-9B84-5A39BD00867E

P478

Q33728277-CEA2A9EC-B4C2-4751-A79F-93623E4FE73A

P50

Q33728277-F59F6422-4BE2-4708-8AB7-ECC6451E21C4

P577

Q33728277-36FAA722-87C9-4AE7-8D95-2F13850A9F84

P698

Q33728277-FBC65E60-C3FB-414D-A468-4EE5B638D2F4

P921

Q33728277-DCBA6A10-3350-46F5-B0A9-5C4D4266E2F3

P932

Q33728277-A46FA96A-01C3-49FF-93F8-9C873FA7A2E7

P356

ONCOTARGET.16320

P1433

P1476

Targeting the PIM protein kina ...... lymphoblastic leukemia subset

@en

P2093

Andrew S Kraft

http://www.w3.org/2001/XMLSchema#string

Jon C Aster

http://www.w3.org/2001/XMLSchema#string

Libia A Luevano

http://www.w3.org/2001/XMLSchema#string

Neha Singh

http://www.w3.org/2001/XMLSchema#string

Ningfei An

http://www.w3.org/2001/XMLSchema#string

Ritu Pandey

http://www.w3.org/2001/XMLSchema#string

Sathish K R Padi

http://www.w3.org/2001/XMLSchema#string

Shikhar Mehrotra

http://www.w3.org/2001/XMLSchema#string

Xue-Zhong Yu

http://www.w3.org/2001/XMLSchema#string

P2860

Bioconductor: open software development for computational biology and bioinformatics

High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol

Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels

Cytoscape: a software environment for integrated models of biomolecular interaction networks

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

The genetic basis of early T-cell precursor acute lymphoblastic leukaemia.

PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers

AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance

PIM1 protein kinase regulates PRAS40 phosphorylation and mTOR activity in FDCP1 cells

Increased expression of the hPim-2 gene in human chronic lymphocytic leukemia and non-Hodgkin lymphoma

P304

30199-30216

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.16320

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28415816

http://www.w3.org/2001/XMLSchema#string

P921

P932

5444737

http://www.w3.org/2001/XMLSchema#string